EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Liposome drug delivery strategies: state-of-the-art for combating bacterial biofilms

Tao Lin, Haifeng Liu, Wei He, Wei Hu, Huifang Jiang, Zhiyang Xu, Jintao Wei, Mingdong Yang, Haibin Dai, Junjun Xu

Frontiers in Microbiology · 30.07.2026 · 17

DOI: 10.3389/fmicb.2026.1899406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 30.07.2026. Verfasst von Tao Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound in Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial biofilms pose a significant challenge in clinical settings due to their inherent resistance to conventional antibiotics and host immune responses. This review comprehensively discusses the application of liposomal drug delivery systems as a cutting-edge strategy to combat biofilm-associated infections. It begins by outlining the biological characteristics of biofilms, including their formation process and the protective extracellular polymeric substance (EPS) matrix. The manuscript then focuses on the advantages of liposomes, such as their nanoscale size effect, modifiable surface properties, and sustained-release capabilities, which enhance penetration through the EPS and improve drug accumulation at infection sites. Furthermore, it details species-specific strategies against pathogens like Staphylococcus aureus , Pseudomonas aeruginosa , and Escherichia coli . The review also covers advanced mechanisms including quorum sensing interference, stimuli-responsive release (pH, enzyme, temperature), and synergistic therapies combining antibiotics with antimicrobial peptides or natural products. Finally, it summarizes current clinical studies and outlines future prospects for precision targeting and multi-stimuli responsive systems to improve the treatment of chronic biofilm infections.

Schlagwörter

Stichwörter der Autor:innen

anti-infection therapybacterial bioflimsbioflim barrierdrug delivery systemsliposome

Autor:innen und Institutionen

  • Department of Ultrasound in Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Pharmacy, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Emergency Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Förderung

  • Zhejiang Provincial Natural Science Foundation of China

Zitieren

APA

Lin, T., Liu, H., He, W., Hu, W., Jiang, H., Xu, Z., Wei, J., Yang, M., Dai, H., & Xu, J. (2026). Liposome drug delivery strategies: state-of-the-art for combating bacterial biofilms. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1899406

Vancouver

Lin T, Liu H, He W, Hu W, Jiang H, Xu Z, et al. Liposome drug delivery strategies: state-of-the-art for combating bacterial biofilms. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1899406

BibTeX
@article{Lin2026,
  author = {Lin, Tao and Liu, Haifeng and He, Wei and Hu, Wei and Jiang, Huifang and Xu, Zhiyang and Wei, Jintao and Yang, Mingdong and Dai, Haibin and Xu, Junjun},
  title = {Liposome drug delivery strategies: state-of-the-art for combating bacterial biofilms},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1899406}
}
Kostenlos starten →